GlassScriptPhysician profile
Daniel J Kohane
NPI 1235399734
$26,628.72
in general payments reported to CMS, 2019-2025
63 companies · $3,047 in 2025
The $3,047 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,241 · 2020: $1,628 · 2021: $3,434 · 2022: $3,182 · 2023: $3,301 · 2024: $9,797 · 2025: $3,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,980 · Long Term Medical Supply Or Device Loan: $7,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,980.11 |
| Long Term Medical Supply Or Device Loan | $7,164.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $7,164.40 | 2024 | Rs-Lbg, Rs-Fbg, Rs 4i Plus Sequential Stimulator |
| Collegium Pharmaceutical, INC. | $2,298.64 | 2019-2025 | Xtampza, Belbuca, Nucynta |
| Boston Scientific Corporation | $2,297.73 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,741.00 | 2019-2025 | Proclaim |
| Abbvie INC. | $1,066.79 | 2021-2025 | |
| Relievant Medsystems, INC. | $906.91 | 2019-2023 | Intracept |
| Nevro Corp. | $897.10 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $755.70 | 2019-2025 | Ztlido |
| Forte Bio-Pharma LLC | $727.49 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Medtronic, INC. | $635.38 | 2021-2025 | Accurian, Vanta Adaptivestim, Intellis Adaptivestim |
| Biodelivery Sciences International, INC. | $608.44 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $456.93 | 2024-2025 | |
| Saluda Medical Americas, INC. | $455.91 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $440.98 | 2023-2025 | Qutenza |
| Vertos Medical, INC. | $404.08 | 2019-2023 | Mild Device Kit |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $402.17 | 2019-2024 | |
| Nalu Medical, INC. | $366.12 | 2023-2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $329.93 | 2019-2024 | Relistor |
| Horizon Therapeutics Plc | $317.26 | 2019-2022 | |
| Medtronic USA, INC. | $316.40 | 2019-2020 | |
| Pfizer INC. | $309.47 | 2019-2025 | |
| Azurity Pharmaceuticals, INC. | $305.87 | 2023-2025 | Horizant, Horizant |
| Zyla Life Sciences, INC. | $293.92 | 2019-2020 | |
| Virtus Pharmaceuticals LLC | $279.77 | 2020-2021 | |
| Protega Pharmaceutials INC | $184.59 | 2024-2025 | Roxybond |
| Arbor Pharmaceuticals, INC. | $180.62 | 2019-2022 | |
| Fidia Pharma USA INC. | $154.09 | 2019-2024 | Hym/Hyn, Hymovis, Triluron |
| Amgen INC. | $150.37 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $140.69 | 2019-2020 | |
| Ibsa Pharma INC. | $139.30 | 2020-2024 | Tirosint, Licart, Licart |
| Kowa Pharmaceuticals America, INC. | $138.91 | 2022-2023 | Seglentis |
| Biohaven Pharmaceuticals, INC. | $126.44 | 2021 | |
| Redhill Biopharma INC. | $120.62 | 2020-2022 | |
| Mml US, INC. | $118.24 | 2023 | Reactiv8 |
| Djo, LLC | $114.06 | 2024 | Cmf |
| Biotronik Nro, INC. | $100.62 | 2025 | Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $96.45 | 2022 | |
| Lundbeck LLC | $95.31 | 2024-2025 | Vyepti |
| Depuy Synthes Sales INC. | $85.11 | 2021-2024 | Orthovisc |
| Daiichi Sankyo INC. | $83.52 | 2019 | |
| Assertio Therapeutics, INC. | $61.45 | 2019-2020 | |
| Bioventus LLC | $61.43 | 2021-2024 | Gelsyn-3 |
| Axsome Therapeutics, INC. | $51.30 | 2025 | Symbravo |
| Grt US Holding, INC. | $51.27 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.03 | 2019 | |
| Stimwave Technologies Incorporated | $50.00 | 2020 | |
| Valinor Pharma, LLC | $46.51 | 2023-2025 | Movantik |
| Curonix LLC | $46.37 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mdd US Operations, LLC | $46.09 | 2020 | |
| Sentynl Therapeutics, INC. | $40.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $39.57 | 2019 | |
| Almatica Pharma LLC | $37.83 | 2022 | |
| Inspire Medical Systems, INC. | $37.33 | 2023 | Inspire |
| Uswm, LLC | $27.30 | 2021 | |
| Allergan, INC. | $26.68 | 2019 | |
| Ferring Pharmaceuticals INC. | $24.91 | 2024 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $23.95 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Baudax Bio INC. | $18.97 | 2020 | |
| Stryker Corporation | $18.27 | 2025 | Optablate |
| Shionogi INC | $17.15 | 2019 | |
| Tonix Medicines, INC. | $16.40 | 2025 | Tonmya |
| Sanofi-Aventis U.S. LLC | $14.56 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kohane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.